UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maternal buprenorphine treatment and fetal neurobehavioral development

American journal of obstetrics and gynecology, 2017-05, Vol.216 (5), p.529.e1-529.e8

2017

Volltextzugriff (PDF)

Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review

Trials, 2020-03, Vol.21 (1), p.262-14, Article 262

2020

Volltextzugriff (PDF)

Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research

Frontiers in pediatrics, 2024-05, Vol.12, p.1349102-1349102

2024

Volltextzugriff (PDF)

Maternal Alcohol Use During Lactation and Child Development

Pediatrics (Evanston), 2018-08, Vol.142 (2)

Jansson, Lauren M.

2018

Volltextzugriff (PDF)

Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence–based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS

Neurotoxicology and teratology, 2021-11, Vol.88, p.107032, Article 107032

2021

Volltextzugriff (PDF)

Perinatal Marijuana Use and the Developing Child

JAMA : the journal of the American Medical Association, 2018-08, Vol.320 (6), p.545

2018

Volltextzugriff (PDF)

The opioid-exposed newborn: assessment and pharmacologic management

Journal of opioid management, 2009, Vol.5 (1), p.47-55

2009

Volltextzugriff (PDF)

Re: Neonatal Abstinence Syndrome and High School Performance

Pediatrics (Evanston), 2017-06, Vol.139 (6)

2017

Volltextzugriff (PDF)

A Core Outcome Set for Neonatal Opioid Withdrawal Syndrome

Pediatrics, 2020-07, Vol.146 (1), p.1

2020

Volltextzugriff (PDF)

Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants

Acta Paediatrica, 2013-11, Vol.102 (11), p.1060-1066

2013

Volltextzugriff (PDF)

Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate

The Journal of pediatrics, 2022-04, Vol.243, p.33-39.e1

2022

Volltextzugriff (PDF)

Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach

Neurotoxicology and teratology, 2021-11, Vol.88, p.107020-107020, Article 107020

2021

Volltextzugriff (PDF)

Gestational buprenorphine-naloxone exposure and fetal neurobehavior

Neurotoxicology and teratology, 2024-07, Vol.104, p.107368, Article 107368

2024

Volltextzugriff (PDF)

A Dyadic Framework of Care for Opioid-exposed Birthing Persons and Their Infants and Children

The Journal of pediatrics, 2024-03, Vol.266, p.113893-113893, Article 113893

2024

Volltextzugriff (PDF)

Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review

Journal of perinatology, 2021-06, Vol.41 (6), p.1364-1371

2021

Volltextzugriff (PDF)

Buprenorphine-Naloxone Maintenance and Lactation

Journal of human lactation, 2024-02, Vol.40 (1), p.113-119

2024

Volltextzugriff (PDF)

The Opioid Dependent Mother and Newborn Dyad: Nonpharmacologic Care

Journal of addiction medicine, 2008-09, Vol.2 (3), p.113-120

2008

Volltextzugriff (PDF)

Maternal treatment with opioid analgesics and risk for birth defects: additional considerations

American journal of obstetrics and gynecology, 2011-09, Vol.205 (3), p.e12-e12

2011

Volltextzugriff (PDF)

Infant autonomic functioning and neonatal abstinence syndrome

Drug and alcohol dependence, 2010-06, Vol.109 (1), p.198-204

2010

Volltextzugriff (PDF)

Methadone and perinatal outcomes: another perspective

American journal of obstetrics and gynecology, 2011-11, Vol.205 (5), p.e11-e11

2011

Volltextzugriff (PDF)

Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial

Journal of perinatology, 2023-03, Vol.43 (3), p.271-276

2023

Volltextzugriff (PDF)

Maternal buprenorphine treatment and infant outcome

Drug and alcohol dependence, 2017-11, Vol.180, p.56-61

2017

Volltextzugriff (PDF)

Validation of a LC–APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-09, Vol.856 (1), p.267-272

2007

Volltextzugriff (PDF)

Prenatal buprenorphine exposure and neonatal neurobehavioral functioning

Early human development, 2018-02, Vol.117, p.7-14

2018

Volltextzugriff (PDF)

Maternal buprenorphine treatment during pregnancy and maternal physiology

Drug and alcohol dependence, 2019-08, Vol.201, p.38-44

2019

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(71)
Humans
(63)
Female
(56)
Pregnancy
(48)
Infant, Newborn
(35)
Adult
(28)
Neonatal Abstinence Syndrome
(27)
Pediatrics
(27)
Substance Abuse
(26)
Methadone
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Obstetrics & Gynecology
(19)
Infant
(16)
Psychiatry
(16)
Opioid-Related Disorders - Drug Therapy
(15)
Opioids
(15)
Infants
(14)
Methadone - Adverse Effects
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maternal buprenorphine treatment and fetal neurobehavioral development

Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review

Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research

Maternal Alcohol Use During Lactation and Child Development

Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence–based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS

Perinatal Marijuana Use and the Developing Child

The opioid-exposed newborn: assessment and pharmacologic management

Re: Neonatal Abstinence Syndrome and High School Performance

A Core Outcome Set for Neonatal Opioid Withdrawal Syndrome

Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants

Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate

Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach

Gestational buprenorphine-naloxone exposure and fetal neurobehavior

A Dyadic Framework of Care for Opioid-exposed Birthing Persons and Their Infants and Children

Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review

Buprenorphine-Naloxone Maintenance and Lactation

The Opioid Dependent Mother and Newborn Dyad: Nonpharmacologic Care

Maternal treatment with opioid analgesics and risk for birth defects: additional considerations

Infant autonomic functioning and neonatal abstinence syndrome

Methadone and perinatal outcomes: another perspective

Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial

Maternal buprenorphine treatment and infant outcome

Validation of a LC–APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation

Prenatal buprenorphine exposure and neonatal neurobehavioral functioning

Maternal buprenorphine treatment during pregnancy and maternal physiology

Suchergebnisse filtern